CA2707445A1 - Inhibiteurs tetrahydro-isoquinolino de ppat utilises en tant qu'agents antibacteriens - Google Patents

Inhibiteurs tetrahydro-isoquinolino de ppat utilises en tant qu'agents antibacteriens Download PDF

Info

Publication number
CA2707445A1
CA2707445A1 CA2707445A CA2707445A CA2707445A1 CA 2707445 A1 CA2707445 A1 CA 2707445A1 CA 2707445 A CA2707445 A CA 2707445A CA 2707445 A CA2707445 A CA 2707445A CA 2707445 A1 CA2707445 A1 CA 2707445A1
Authority
CA
Canada
Prior art keywords
independently
compound
alkyl
aryl
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2707445A
Other languages
English (en)
Inventor
Roger Frechette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2707445A1 publication Critical patent/CA2707445A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA2707445A 2007-11-30 2008-11-26 Inhibiteurs tetrahydro-isoquinolino de ppat utilises en tant qu'agents antibacteriens Abandoned CA2707445A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99152507P 2007-11-30 2007-11-30
US60/991,525 2007-11-30
PCT/US2008/084948 WO2009073545A2 (fr) 2007-11-30 2008-11-26 Inhibiteurs tétrahydro-isoquinolino de ppat utilisés en tant qu'agents antibactériens

Publications (1)

Publication Number Publication Date
CA2707445A1 true CA2707445A1 (fr) 2009-06-11

Family

ID=40718459

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2707445A Abandoned CA2707445A1 (fr) 2007-11-30 2008-11-26 Inhibiteurs tetrahydro-isoquinolino de ppat utilises en tant qu'agents antibacteriens

Country Status (6)

Country Link
EP (1) EP2225207A2 (fr)
JP (1) JP2011518109A (fr)
CN (1) CN102007101A (fr)
AU (1) AU2008334075A1 (fr)
CA (1) CA2707445A1 (fr)
WO (1) WO2009073545A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009073534A2 (fr) 2007-11-30 2009-06-11 Maxthera Inc. Inhibiteurs de ppat bicycliques utilisés en tant qu'agents antibactériens
FR2986002B1 (fr) 2012-01-24 2014-02-21 Servier Lab Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN102603755B (zh) * 2012-02-08 2015-09-09 中国人民解放军第二军医大学 一类具有协同氟康唑抗耐药真菌作用的化合物
FR3008975A1 (fr) * 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008977A1 (fr) 2013-07-23 2015-01-30 Servier Lab Nouveaux derives d'isoindoline ou d'isoquinoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008976A1 (fr) 2013-07-23 2015-01-30 Servier Lab "nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
JP6633618B2 (ja) 2014-08-21 2020-01-22 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 強力なｒｏｃｋ阻害剤としてのタイドバックのベンズアミド誘導体
WO2017025509A1 (fr) * 2015-08-12 2017-02-16 Syngenta Participations Ag Dérivés hétérobicycliques microbiocides
MX2021004566A (es) 2018-10-22 2021-06-08 C4X Discovery Ltd Compuestos terapeuticos.
CN113461699B (zh) * 2021-04-14 2022-06-21 宁波大学 一种四环吡咯生物碱类化合物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2365401A1 (fr) * 1999-03-11 2000-10-05 Neurogen Corporation Pyridines 2,4-disubstituees fusionnees avec un aryle: ligands du recepteur nk-3
US20050070570A1 (en) * 2003-06-18 2005-03-31 4Sc Ag Novel potassium channels modulators
EP1637529A1 (fr) * 2004-09-20 2006-03-22 4Sc Ag Nouveaux analogues de piperidin-4-yl-thiazole-carboxamide en tant qu'inhibiteurs de proliferation de lymphocytes T er leurs utilisations
EP1994017A2 (fr) * 2006-03-15 2008-11-26 4Sc Ag Nouveaux inhibiteurs hétérocycliques de nf/kb

Also Published As

Publication number Publication date
WO2009073545A3 (fr) 2009-09-11
AU2008334075A1 (en) 2009-06-11
JP2011518109A (ja) 2011-06-23
WO2009073545A2 (fr) 2009-06-11
CN102007101A (zh) 2011-04-06
EP2225207A2 (fr) 2010-09-08

Similar Documents

Publication Publication Date Title
CA2707445A1 (fr) Inhibiteurs tetrahydro-isoquinolino de ppat utilises en tant qu'agents antibacteriens
ES2558685T3 (es) Uso de compuestos de pirroloquinolina para eliminar microorganismos clínicamente latentes
EP2609082B1 (fr) Imidazo[4,5-c]quinolines utilisés en tant qu'inhibiteurs d'adn-pk
ES2602203T3 (es) Derivados de sulfóxido para el tratamiento de tumores
MX2015006168A (es) Compuestos de pirrolopirimidina como inhibidores de quinasas.
US8124616B2 (en) Bicyclic PPAT inhibitors as antibacterial agents
JP5143000B2 (ja) 抗感染症薬としての８−メトキシ−９Ｈ−イソチアゾロ［５，４−ｂ］キノリン−３，４−ジオンおよび関連化合物
KR102348014B1 (ko) Crth2 길항제로서의 화합물 및 그 용도
EP3110819A1 (fr) Composés hétérocycliques
EP1628977B1 (fr) DERIVES DE TETRAHYDRO-b-CARBOLINE ANTIBIOTIQUES
JP2024518447A (ja) ＰＫＣ－θモジュレーター
WO2009102377A2 (fr) Dérivés de tétrahydro-bêta-carboline antibiotiques
EP2897970A1 (fr) Dérivés de macrolide, leur préparation et leur utilisation thérapeutique
US20090203726A1 (en) Substituted tetrahydroquinolines as antibacterial agents
WO2004064837A1 (fr) Antibacterien inhibiteur du fab i
US11802129B1 (en) Pyrido[3,4-b]indol-1-one compounds as anticancer agents
CA2534957A1 (fr) Derives de cycloalkyltetrahydroquinoline antibiotique
US20230190763A1 (en) Cyclopentathiophene Carboxamide Derivatives as Platelet Activating Factor Receptor Antagonists
JP2008528551A (ja) インドロピリジン、ベンゾフラノピリジン及びベンゾチエノピリジン

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20121126